JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
83 hedge funds and large institutions have $210M invested in Jounce Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 31 closing their positions.
Holders
83
Holders Change
-11
Holders Change %
-11.7%
% of All Funds
1.9%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
20
Increased
28
Reduced
22
Closed
31
Calls
$2.1M
Puts
$1.15M
Net Calls
+$950K
Net Calls Change
-$18.8M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$5.2M |
| 2 |
2
BlackRock
New York
|
$10.7M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$4.09M |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$2.41M |
| 5 |
5
Two Sigma Investments
New York
|
$1.56M |
